#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic intracranial hypertension Fragile X syndrome Dementia Solitary fibrous tumour Neonatal alloimmune thrombocytopenia Testicular leiomyosarcoma Ovarian cancer stage III Myelodysplastic syndrome Thermal burn Conjunctivitis allergic Cutaneous lupus erythematosus Polycystic liver disease Anal fistula Cutaneous T-cell lymphoma recurrent Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Life with Disease Glomerulonephritis membranoproliferative – Treatment Primary mediastinal large B-cell lymphoma – Life with Disease Haemolytic uraemic syndrome – Trials in Disease X-linked lymphoproliferative syndrome – Trials in Disease Amyotrophic lateral sclerosis – Treatment Systemic mastocytosis – Trials in Disease Lysosomal storage disorder – Diagnostics Methylmalonic acidaemia – Treatment Friedreich’s ataxia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meclofenamate Sodium Gedatolisib Dorocubicel Zolbetuximab Pramipexole Cd19-Car_Lenti_Allo Prednisone GSK5458514 Io103 Acetate Nystatin EGANELISIB Nizaracianine Triflutate Peposertib Sodium Oxybate Isoflurane E2814 BNT327 STREPTOCOCCUS PYOGENES Mps-215 Desonide More therapies…

    Learn about Your Condition

    Critical illness Procedural haemorrhage Systemic infection Laryngeal cancer Generalised anxiety disorder Paresis Polyneuropathy Placenta praevia Seizure Electronic cigarette user Allergic respiratory disease Glomerulonephritis acute Small cell carcinoma Sarcoma Hyperparathyroidism secondary More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z…

Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o.

Ul. Marcelinska 92, Poznan, 60-324, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Tocilizumab
    Bulgaria Czechia Estonia Hungary Lithuania Poland +1

  • Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic sclerosis pulmonary
    Investigated Drugs:
    • Tulisokibart
    Belgium France Germany Hungary Italy The Netherlands +2

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Mercaptopurine
    • Methotrexate Sodium
    • Vixarelimab
    Belgium Czechia France Germany Greece Italy +1

  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Bulgaria France Greece Poland Spain Sweden

  • Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Bulgaria Czechia Germany Poland Spain

  • Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Zasocitinib
    • Apremilast
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study on the Effects of Ritlecitinib in Patients Aged 12 and Older with Alopecia Areata

    Not recruiting

    3 1 1
    Czechia Poland Spain
Previous Page
1 2 3 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!